CRISPR/Cas9-mediated gene editing in human tripronuclear zygotes
about
A Broad Overview and Review of CRISPR-Cas Technology and Stem CellsSpermatogonial stem cell autotransplantation and germline genomic editing: a future cure for spermatogenic failure and prevention of transmission of genomic diseasesCRISPR/Cas9: Implications for Modeling and Therapy of Neurodegenerative DiseasesGenetic manipulation for inherited neurodegenerative diseases: myth or reality?The therapeutic potential of genome editing for β-thalassemiaGenome Editing and Its Applications in Model OrganismsTowards a new era in medicine: therapeutic genome editingNanotechnologies for biomedical science and translational medicineOrigins of Programmable Nucleases for Genome EngineeringSynthetic biology and occupational riskHematopoietic Stem Cells in Regenerative Medicine: Astray or on the Path?CRISPR/Cas9 and mitochondrial gene replacement therapy: promising techniques and ethical considerationsTargeted genome editing in primate embryosThe CRISPR system can correct or modify the expression of genes responsible for hereditary diseasesEfficient and versatile CRISPR engineering of human neurons in culture to model neurological disordersCRISPR/Cas9-mediated targeted gene correction in amyotrophic lateral sclerosis patient iPSCs.CRISPR/Cas9 Immune System as a Tool for Genome Engineering.Genetic Engineering and Human Mental Ecology: Interlocking Effects and Educational Considerations.A CRISPR New World: Attitudes in the Public toward Innovations in Human Genetic Modification.Genome Editing and Muscle Stem Cells as a Therapeutic Tool for Muscular Dystrophies.Potential Value of Genomic Copy Number Variations in Schizophrenia.Gene Therapy 2017: Progress and Future Directions.The moral imperative to continue gene editing research on human embryos.Human Germline CRISPR-Cas Modification: Toward a Regulatory Framework.What is CRISPR/Cas9?Induced Pluripotent Stem Cells Meet Genome EditingBreaking-Cas-interactive design of guide RNAs for CRISPR-Cas experiments for ENSEMBL genomes.Applications of CRISPR technologies in research and beyond.Core Concept: CRISPR gene editing.Eliminate mitochondrial diseases by gene editing in germ-line cells and embryos.Ethics and germline gene editing.A double-edged sword: CRISPR-Cas9 is emerging as a revolutionary technique for genome editingThe societal opportunities and challenges of genome editing.US Competitiveness in Synthetic Biology.Human germ line editing-roles and responsibilitiesThe moral concerns of biobank donors: the effect of non-welfare interests on willingness to donate.Gene Editing and Germ-line Intervention: The Need for Novel Responses to Novel TechnologiesModifying the Mitochondrial Genome.Sites of retroviral DNA integration: From basic research to clinical applicationsIntroducing precise genetic modifications into human 3PN embryos by CRISPR/Cas-mediated genome editing.
P2860
Q26741371-F092D0C3-D465-4DD4-B673-88F883B138A8Q26744780-43B7EA56-C667-4722-86A0-22A1065A9B1DQ26747564-D00C7C53-8EAE-4AC5-8C3E-0B61ABF01FC2Q26752831-ED5E1009-8D3F-408D-9288-6E25FBABFA0EQ26766232-A8AA03FC-EB17-4DFD-A763-5FD820C6B921Q26772108-1A066EB3-A1CD-49F4-8A9A-746D68AE7FD3Q26773287-D8B52182-B422-4AF8-BB2A-58AFA8FB028AQ26776376-24EC4CBD-CA00-4AA7-BD14-58109D36CEEFQ26778501-AB136E9F-B70D-4C5A-8A01-C1254988C52BQ27968974-25E921A7-B4C2-4BF0-9F2A-2B2C3B50567EQ28072887-24BCFA92-70C5-4F3C-BD68-FCB7DC48CE7FQ28073860-0242D2F1-33A9-499B-8EF9-6020F6D78BB2Q28080423-05804E18-A6AC-4865-9675-E092F6E2F567Q28085767-5BEE6B05-B787-47B1-B13D-75393C2FDF23Q28588457-22248A61-6198-4E3E-8770-CE2413FD87C0Q33628110-5DE5AF95-7487-4D8D-ADA7-D9E458493D5FQ33695238-318F7D2E-4C62-4938-816F-FB4AEB9A4E14Q33705114-E69181A9-F27C-4989-B5E5-22CC1193B7B5Q33711428-DB5155CC-E1F4-4C86-9390-CD99804E6A9FQ33729585-3C0AA162-5BC2-4F54-A85B-3B62E303C3A8Q33819207-B6E648A4-286E-4FF6-9687-C25A0C730C98Q33891559-23D30D9F-73FC-4A83-9E56-E734A964310FQ34482434-6B278152-E436-4287-B932-A09E6851AE6FQ34503980-B0ACB99E-7557-4401-9AC0-A0F262AE7238Q34521342-871F6231-0212-4D95-B85B-DCD08B11C0A2Q34525438-0EEE18D7-ACD3-436A-8681-76B0DE90E683Q34526018-1318722B-79C1-4378-BF13-D8C78E0B05C8Q34539796-1C70A191-1698-4F73-B429-B9303CDA0F81Q35644973-273A7B7F-5433-48DC-9D10-4BE2988C3E69Q35816077-B441F721-A8B6-4AD4-B48A-3F0EA2417B68Q36004227-608DE9C8-D60F-4A35-98D7-298A6BBDE739Q36165753-0EB6FC71-AB46-41A9-9491-117538EE09C7Q36253010-0FCA59BC-EBA0-4516-A662-73DDF7B91FC9Q36388406-A963B387-A78D-456D-8E6E-7AD06C7A8ACBQ36447877-97486F0F-E58E-4107-ACC0-D91A88B4DEE5Q36678411-A03D8214-7C33-4F53-974D-99145241B71CQ36757166-B78AD046-0A0B-4261-ADB7-40A50AA57D11Q36894373-3BF52DEE-B22D-46AD-9695-5D53044303FAQ36900663-484DB584-DE04-4D19-A7AB-A5BCFB17A08EQ36910225-C756F51A-BBB2-443B-9AC8-9B75F33AF133
P2860
CRISPR/Cas9-mediated gene editing in human tripronuclear zygotes
description
2015 nî lūn-bûn
@nan
2015 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2015 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
name
CRISPR/Cas9-mediated gene editing in human tripronuclear zygotes
@ast
CRISPR/Cas9-mediated gene editing in human tripronuclear zygotes
@en
CRISPR/Cas9-mediated gene editing in human tripronuclear zygotes
@en-gb
CRISPR/Cas9-mediated gene editing in human tripronuclear zygotes
@nl
type
label
CRISPR/Cas9-mediated gene editing in human tripronuclear zygotes
@ast
CRISPR/Cas9-mediated gene editing in human tripronuclear zygotes
@en
CRISPR/Cas9-mediated gene editing in human tripronuclear zygotes
@en-gb
CRISPR/Cas9-mediated gene editing in human tripronuclear zygotes
@nl
prefLabel
CRISPR/Cas9-mediated gene editing in human tripronuclear zygotes
@ast
CRISPR/Cas9-mediated gene editing in human tripronuclear zygotes
@en
CRISPR/Cas9-mediated gene editing in human tripronuclear zygotes
@en-gb
CRISPR/Cas9-mediated gene editing in human tripronuclear zygotes
@nl
P2093
P2860
P921
P3181
P1433
P1476
CRISPR/Cas9-mediated gene editing in human tripronuclear zygotes
@en
P2093
Canquan Zhou
Chenhui Ding
Puping Liang
Xiaowei Xie
Xiya Zhang
P2860
P2888
P304
P3181
P356
10.1007/S13238-015-0153-5
P407
P50
P577
2015-05-01T00:00:00Z
P5875
P6179
1039746439